Morningstar Investment Management’s AbbVie ABBV Stock Holding History

Morningstar Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.22M	Hold	14,799	–	–	0.2%	127
2026 Q1	$3.22M	Buy	14,799 +8,358	+130%	+$1.85M	0.2%	126
2025 Q4	$1.47M	Sell	6,441 -27,852	-81%	-$6.34M	0.09%	191
2025 Q3	$7.94M	Buy	34,293 +32,334	+1,651%	+$6.58M	0.29%	83
2025 Q2	$364K	Buy	+1,959	New	+$364K	0.03%	140
2025 Q1	–	Sell	-2,688	Closed	-$478K	–	72
2024 Q4	$478K	Sell	2,688 -26	-1%	-$4.78K	0.04%	130
2024 Q3	$531K	Sell	2,714 -5,881	-68%	-$1.1M	0.05%	133
2024 Q2	$1.47M	Sell	8,595 -1,071	-11%	-$177K	0.15%	66
2024 Q1	$1.76M	Hold	9,666	–	–	0.19%	56
2023 Q4	$1.5M	Sell	9,666 -273	-3%	-$39.8K	0.17%	64
2023 Q3	$1.48M	Buy	9,939 +445	+5%	+$65.3K	0.2%	44
2023 Q2	$1.28M	Buy	9,494 +5,326	+128%	+$781K	0.17%	47
2023 Q1	$664K	Sell	4,168 -20	-0.5%	-$3.06K	0.1%	50
2022 Q4	$677K	Buy	+4,188	New	+$642K	0.11%	50

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Morningstar Investment Management's ABBV Position: Q2 2026 in Review

Morningstar Investment Management held its AbbVie (ABBV) position steady in Q2 2026 at 14,799 shares worth $3.22M. The position accounts for 0.2% of the portfolio, ranked #127.

Morningstar Investment Management first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. The position peaked at $7.94M in Q3 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Morningstar Investment Management held 14,799 shares of AbbVie worth $3.22M as of Q2 2026.
Morningstar Investment Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.2% of Morningstar Investment Management's portfolio in Q2 2026, its #127 holding.
Morningstar Investment Management first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
Morningstar Investment Management's AbbVie position peaked at $7.94M in Q3 2025.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Morningstar Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.